Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549321 | SCV000651377 | benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000574670 | SCV000674963 | benign | Hereditary cancer-predisposing syndrome | 2015-04-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Institute for Clinical Genetics, |
RCV001572933 | SCV002009961 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000574670 | SCV002527710 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-26 | criteria provided, single submitter | curation | |
Diagnostic Laboratory, |
RCV001528282 | SCV001739765 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001572933 | SCV001798059 | likely benign | not provided | no assertion criteria provided | clinical testing |